27-28 June 2018 | ExCel London

Subpage image

Biogen Idec

Stand: Q48

 Through cutting-edge science, Biogen discovers, develops and delivers innovative therapies for people living with serious neurological and autoimmune diseases. In 2012, Biogen entered into a joint venture with Samsung Biologics to develop, manufacture and market biosimilars of advanced biologics. Biogen currently has two anti-TNF biosimilars licensed for use in Europe.

Website

http://www.biogen.com
Contact Exhibitor

Contact Exhibitor


Loading
View all Exhibitors

Confirmed Speakers

 

Sponsors

Sponsors

Sponsors

Sponsors

Sponsors

Sponsors

In Partnership With




 

Official Media Partner

In Association With

In Association With

 

In Association With

In Association With

In Association With

 

In Association With

 

Supported By

 

Supported By

Supported By

 

Supported By